214
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Development and Validation of a Multivariable Prediction Model to Identify Acute Exacerbation of COPD and Its Severity for COPD Management in China (DETECT Study): A Multicenter, Observational, Cross-Sectional Study

ORCID Icon, ORCID Icon, , , , , & show all
Pages 2093-2106 | Received 16 Mar 2022, Accepted 17 Aug 2022, Published online: 05 Sep 2022

References

  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (2022 report); 2022. Available from: https://goldcopd.org/wp-content/uploads/2021/12/GOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdf. Accessed February 14, 2022.
  • Fang L, Gao P, Bao H, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. Lancet Respir Med. 2018;6(6):421–430. doi:10.1016/S2213-2600(18)30103-6
  • Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;394(10204):1145–1158. doi:10.1016/S0140-6736(19)30427-1
  • Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–555. doi:10.1164/rccm.200703-456SO
  • Guo J, Chen Y, Zhang W, Tong S, Dong J. Moderate and severe exacerbations have a significant impact on health-related quality of life, utility, and lung function in patients with chronic obstructive pulmonary disease: a meta-analysis. Int J Surg. 2020;78:28–35. doi:10.1016/j.ijsu.2020.04.010
  • Cai BQ, Cai SX, Chen RC, et al. Expert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People’s Republic of China. Int J Chron Obstruct Pulmon Dis. 2014;9:381–395. doi:10.2147/COPD.S58454
  • Zhang Y, Lin YX. Risk factors analysis for one-year and long-term mortality in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease [in Chinese]. Chin J Tuberc Respir Dis. 2019;42(12):895–900.
  • Liang L, Shang Y, Xie W, Shi J, Tong Z, Jalali MS. Trends in hospitalization expenditures for acute exacerbations of COPD in Beijing from 2009 to 2017. Int J Chron Obstruct Pulmon Dis. 2020;15:1165–1175. doi:10.2147/COPD.S243595
  • Wilkinson TMA, Donaldson GC, Hurst JR, Seemungal TAR, Wedzicha JA. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;169(12):1298–1303. doi:10.1164/rccm.200310-1443OC
  • Montes de Oca M, Laucho-Contreras ME. Is it time to change the definition of acute exacerbation of chronic obstructive pulmonary disease? What do we need to add? Med Sci. 2018;6(2):50. doi: 10.3390/medsci6020050
  • Shen N, He B. Is the new GOLD classification applicable in China? Lancet Glob Health. 2013;1(5):e247–e248. doi:10.1016/S2214-109X(13)70064-0
  • Zhou XM, Wu C, Zhao L, et al. A cross-sectional survey of the knowledge on chronic obstructive pulmonary disease in physicians of tertiary hospitals in Northern China [in Chinese]. Chin J Internal Med. 2016;55(9):717–720.
  • Guerra B, Gaveikaite V, Bianchi C, Puhan MA. Prediction models for exacerbations in patients with COPD. Eur Respir Rev. 2017;26(143):160061. doi:10.1183/16000617.0061-2016
  • Mackay AJ, Donaldson GC, Patel ARC, Singh R, Kowlessar B, Wedzicha JA. Detection and severity grading of COPD exacerbations using the exacerbations of chronic pulmonary disease tool (EXACT). Eur Respir J. 2014;43(3):735–744. doi:10.1183/09031936.00110913
  • Global Initiative for Obstructive Lung Disease. Pocket guide to COPD diagnosis, management, and prevention; a guide for health care professionals; 2017. Available from: http://goldcopd.org/wp-content/uploads/2016/12/wms-GOLD-2017-Pocket-Guide.pdf. Accessed February 14, 2022.
  • Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3(1):17. doi:10.1186/1751-0473-3-17
  • Iba K, Shinozaki T, Maruo K, Noma H. Re-evaluation of the comparative effectiveness of bootstrap-based optimism correction methods in the development of multivariable clinical prediction models. BMC Med Res Methodol. 2021;21(1):9. doi:10.1186/s12874-020-01201-w
  • Harrell JFE. Regression Modeling Strategies with Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis. 2nd ed. New York: Springer; 2015.
  • Herer B, Chinet T. Acute exacerbation of COPD during pulmonary rehabilitation: outcomes and risk prediction. Int J Chron Obstruct Pulmon Dis. 2018;13(13):1767–1774. doi:10.2147/COPD.S163472
  • Tavakoli H, Chen W, Sin DD, FitzGerald JM, Sadatsafavi M. Predicting severe chronic obstructive pulmonary disease exacerbations. Developing a population surveillance approach with administrative data. Ann Am Thorac Soc. 2020;17(9):1069–1076. doi:10.1513/AnnalsATS.202001-070OC
  • Trappenburg JCA, Touwen I, de Weert-van Oene GH, et al. Detecting exacerbations using the clinical COPD questionnaire. Health Qual Life Outcomes. 2010;8:102. doi:10.1186/1477-7525-8-102
  • Jones PW, Wang C, Chen P, et al. The development of a COPD exacerbation recognition tool (CERT) to help patients recognize when to seek medical advice. Int J Chron Obstruct Pulmon Dis. 2022;17:213–222. doi:10.2147/COPD.S337644
  • Claxton S, Porter P, Brisbane J, et al. Identifying acute exacerbations of chronic obstructive pulmonary disease using patient-reported symptoms and cough feature analysis. NPJ Digit Med. 2021;4(1):107. doi:10.1038/s41746-021-00472-x
  • Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa0909883
  • Meeraus WH, Mullerova H, El Baou C, Fahey M, Hessel EM, Fahy WA. Predicting re-exacerbation timing and understanding prolonged exacerbations: an analysis of patients with COPD in the ECLIPSE cohort. Int J Chron Obstruct Pulmon Dis. 2021;16:225–244. doi:10.2147/COPD.S279315
  • Gil HI, Zo S, Jones PW, et al. Clinical characteristics of COPD patients according to COPD assessment test (CAT) score level: cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2021;16:1509–1517. doi:10.2147/COPD.S297089
  • Shah SA, Velardo C, Farmer A, Tarassenko L. Exacerbations in chronic obstructive pulmonary disease: identification and prediction using a digital health system. J Med Internet Res. 2017;19(3):e69. doi:10.2196/jmir.7207
  • Allegra L, Blasi F, Diano P, et al. Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease. Respir Med. 2005;99(6):742–747. doi:10.1016/j.rmed.2004.10.020
  • Stone RA, Lowe D, Potter JM, Buckingham RJ, Roberts CM, Pursey NJ. Managing patients with COPD exacerbation: does age matter? Age Ageing. 2012;41(4):461–468. doi:10.1093/ageing/afs039
  • Kilic H, Kokturk N, Sari G, Cakır M. Do females behave differently in COPD exacerbation? Int J Chron Obstruct Pulmon Dis. 2015;10:823–830. doi:10.2147/COPD.S78952
  • Hunter LC, Lee RJ, Butcher I, et al. Patient characteristics associated with risk of first hospital admission and readmission for acute exacerbation of chronic obstructive pulmonary disease (COPD) following primary care COPD diagnosis: a cohort study using linked electronic patient records. BMJ Open. 2016;6(1):e009121. doi:10.1136/bmjopen-2015-009121
  • Santibáñez M, Garrastazu R, Ruiz-Nuñez M, et al. Predictors of hospitalized exacerbations and mortality in chronic obstructive pulmonary disease. PLoS One. 2016;11(6):e0158727. doi:10.1371/journal.pone.0158727
  • Park HJ, Byun MK, Kim T, et al. Frequent outpatient visits prevent exacerbation of chronic obstructive pulmonary disease. Sci Rep. 2020;10(1):6049. doi:10.1038/s41598-020-63064-x
  • George J, Kong DC, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest. 2005;128(5):3198–3204. doi:10.1378/chest.128.5.3198
  • Vestbo J, Anderson JA, Calverley PM, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64(11):939–943. doi:10.1136/thx.2009.113662
  • Crook S, Büsching G, Keusch S, et al. The association between daily exacerbation symptoms and physical activity in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2018;13:2199–2206. doi:10.2147/COPD.S156986
  • Sun T, Li X, Cheng W, et al. The relationship between morning symptoms and the risk of future exacerbations in COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:1899–1907. doi:10.2147/COPD.S255030
  • Rennard S, Decramer M, Calverley PM, et al. Impact of COPD in North America and Europe in 2000: subjects’ perspective of confronting COPD international survey. Eur Respir J. 2002;20(4):799–805. doi:10.1183/09031936.02.03242002
  • Yang H, Wang H, Du L, Wang Y, Wang X, Zhang R. Disease knowledge and self-management behavior of COPD patients in China. Medicine. 2019;98(8):e14460. doi:10.1097/MD.0000000000014460
  • Grant SW, Collins GS, Nashef SAM. Statistical primer: developing and validating a risk prediction model. Eur J Cardiothorac Surg. 2018;54(2):203–208. doi:10.1093/ejcts/ezy180
  • Chowdhury MZI, Turin TC. Variable selection strategies and its importance in clinical prediction modelling. Fam Med Community Health. 2020;8(1):e000262. doi:10.1136/fmch-2019-000262